depressed, depression, moody, melancholy

Depressed Jane

Let Me Tell You More About My Depressed, Miserable Existence

For Bipolar Depression, Surveyed Experts Indicate That Current And Emerging Therapies Have No Advantage Over Seroquel In Decreasing The Syptoms

Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed psychiatrists identify a therapy’s effect on decrease in severity of depressive symptoms as the attribute that most influences their prescribing decisions in bipolar depression.

Popularity: unranked [?]

Post to Twitter Post to Delicious Post to Digg Post to Facebook Post to Reddit

Related posts:

  1. Current And Emerging Drugs Continue To Struggle For Patient Share In The Treatment Of Major Depressive Disorder
  2. Lexapro Loses First-Line Position For The Treatment Of Major Depression
  3. Lexapro Loses First-Line Position For The Treatment Of Major Depression
  4. Astrazeneca Submits Seroquel XR For The Treatment Of Bipolar Mania And Bipolar Depression, And Seroquel(R) For The Treatment Of Bipolar Depression
  5. Combined Data From Four Large-Scale Studies Demonstrate The Efficacy And Tolerability Of Seroquel In Bipolar Depression

Comments

No Responses to “For Bipolar Depression, Surveyed Experts Indicate That Current And Emerging Therapies Have No Advantage Over Seroquel In Decreasing The Syptoms”

Write a Comment